CAS: 1354039-86-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ACT 335827 REF: 3D-EEC03986CAS: 1354039-86-3 | Min. 95% | 232.00 €~1,855.00 € | Tue 07 Jan 25 |
 | ACT 335827 REF: TM-T21850CAS: 1354039-86-3 | - - - | 1,040.00 €~4,194.00 € | Tue 28 Jan 25 |
ACT 335827
CAS:1354039-86-3
ACT 335827 is a drug that is effective in the treatment of hypertension. It has …
Formula:
C31H38N2O5
Purity:
Min. 95%
Molecular weight:
518.64 g/mol
Ref: 3D-EEC03986
| 1mg | 232.00 € | ||
| 2mg | 364.00 € | ||
| 5mg | 647.00 € | ||
| 10mg | 924.00 € | ||
| 25mg | 1,855.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
ACT 335827
CAS:1354039-86-3
ACT-335827: oral, brain-penetrant OXR1 selective antagonist; IC50: 6 nM (OXR1), 417 nM (OXR2); for neurological …
Formula:
C31H38N2O5
Color and Shape:
Solid
Molecular weight:
518.64
Ref: TM-T21850
| 10mg | 1,040.00 € | ||
| 50mg | 4,194.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
